• hiPSC-Derived Intestinal Organoids Advance PK Modeling

  2026-07-15

  This study introduces a streamlined protocol for generating human intestinal organoids from pluripotent stem cells, enabling more accurate in vitro pharmacokinetic studies. The findings highlight increased physiological relevance and transferability over traditional models, supporting improved drug absorption and metabolism research.

• Human PSC-Derived SAN-Plexus Assembloids Model Pacemaker Mat

  2026-07-15

  This study introduces a tri-assembloid system comprising human pluripotent stem cell-derived sinoatrial node, cardiac plexus, and atrial organoids to recapitulate neuro-cardiac control of pacemaker maturation. By dissecting neuron-to-pacemaker signaling, the work establishes a robust human platform for mechanistic studies of cardiac conduction, disease modeling, and autonomic regulation.

• Brassinolide Applications: Protocols & Troubleshooting for T

  2026-07-14

  Brassinolide (24-Epibrassinolide) stands apart as a validated plant growth regulator and apoptosis inducer, offering reproducible solutions from plant morphogenesis to prostate cancer research. This guide translates structure–activity insights and recent protocol innovations into actionable workflows for both plant and biomedical labs.

• α-KG Restores Mitochondrial Function and Counters HPDLSC Sen

  2026-07-14

  This study elucidates how α-ketoglutarate (α-KG) activates the LKB1-AMPK pathway to alleviate mitochondrial dysfunction and cellular senescence in human periodontal ligament stem cells (HPDLSCs) under inflammatory conditions. The findings provide mechanistic insight into α-KG’s potential as a therapeutic agent for periodontal regeneration in the context of chronic inflammation.

• N1-Methyl-Pseudouridine-5'-Triphosphate: Enhancing mRNA Synt

  2026-07-13

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is reshaping in vitro RNA synthesis by dramatically improving mRNA stability and translation—key for cutting-edge therapeutic and vaccine workflows. Applied research now leverages this modified nucleotide for potent, localized tumor suppressor mRNA delivery, with robust protocols and troubleshooting strategies driving bench-to-clinic success.

• Neuromedin S (rat): Technical Guidance for GPCR Assays

  2026-07-13

  Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for controlled activation of neuromedin U receptor signaling in rat GPCR/G protein pathway research. It is intended for reproducible laboratory workflows involving energy homeostasis regulation and stress response studies, but is not suitable for diagnostic or therapeutic use.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-07-12

  This study provides a detailed molecular and epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the dominance of blaNDM-1 on plasmids, high rates of multidrug resistance, and the efficient horizontal spread of resistance genes, informing future antimicrobial research and infection control strategies.

• Adipose-Neural Axis in Arrhythmias: Insights from Coculture

  2026-07-10

  Fan et al. (2024) demonstrate that the adipose-neural axis, via leptin and neuropeptide Y signaling, is a key mediator of epicardial adipose tissue (EAT)-related cardiac arrhythmias. By employing a stem cell-based coculture system, the study identifies actionable molecular targets for future arrhythmia interventions.

• EdU Imaging Kits (Cy5): Decoding S-Phase Dynamics in Pulmona

  2026-07-09

  Explore how EdU Imaging Kits (Cy5) enable precise cell cycle S-phase DNA synthesis measurement in pulmonary vascular remodeling models. This article reveals advanced assay selection strategies and translates new Pumilio-KCNK3 axis research into actionable protocols for vascular disease studies.

• AZD8055: Technical Guidance for mTOR Inhibition Workflows

  2026-07-09

  AZD8055 is a selective, dual mTORC1/mTORC2 inhibitor designed for mechanistic studies of the mTOR signaling pathway in preclinical models. It is best suited for interrogating cancer and metabolic signaling, but is not intended for studies focused on clinical efficacy endpoints due to limited translational benefit in trials.

• Applied Uses of Cardiogreen (Indocyanine Green) in Advanced

  2026-07-08

  Cardiogreen (Indocyanine Green) empowers translational research and clinical diagnostics by combining high sensitivity vascular imaging with robust photodynamic therapy workflows. Discover protocol-validated use-cases, troubleshooting strategies, and the mechanistic edge this APExBIO dye delivers in both quantitative measurement and cell-targeted therapies.

• Isradipine (Dynacirc) in Calcium Channel Research: Protocols

  2026-07-08

  Isradipine (Dynacirc) offers researchers precision in dissecting L-type calcium channel function, with unique advantages in neuroprotection and vascular studies. This guide translates the latest reference insights and APExBIO’s high-purity formulation into pragmatic protocols, troubleshooting, and next-generation applications.

• BIIE 0246: Decoding Y2R Antagonism for Adipose-Neural Resear

  2026-07-07

  Explore how BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist, enables advanced interrogation of the adipose-neural axis and its impact on cardiac arrhythmia and behavior. This article uniquely integrates mechanistic insights and practical assay considerations for translational neuroscience.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-07-07

  This study establishes a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids capable of long-term propagation and differentiation. The resulting organoids provide a more physiologically relevant in vitro model for pharmacokinetic and drug metabolism research, addressing key limitations of traditional animal and cancer cell line approaches.

• Dehydroabietic Acid: Mechanistic Leverage for Translational

  2026-07-06

  This thought-leadership article explores the dual PPAR-α/γ agonist Dehydroabietic acid (DAA) as a transformative tool for translational metabolic research. Integrating mechanistic insights, strategic workflow guidance, and recent advances in metabolic disorder modeling, it provides a critical roadmap for researchers seeking to exploit DAA’s unique properties for actionable impact in lipid metabolism and insulin sensitivity studies.

16283 records 1/1086 page Next 12345 下5页 Last page